Digestive Health Products Market to reach USD 79.2 Billion by 2030 growing at a CAGR of 8%: Straits Research
May 30, 2022 14:15 ET
|
Straits Research
New York, United States, May 30, 2022 (GLOBE NEWSWIRE) -- Digestive system health products are supplements that help people's digestive health by improving gut function. Foods, functional foods, and...
Global Intestinal Pseudo Obstruction Treatment Market Report 2022: Advancements in Technology and Rising Research Initiatives Towards Products and Treatment Methodologies
May 23, 2022 04:38 ET
|
Research and Markets
Dublin, May 23, 2022 (GLOBE NEWSWIRE) -- The "Global Intestinal Pseudo Obstruction Treatment Market, By Condition (Acute v/s Chronic), By Diagnosis (Physical Examination, Biopsy, Blood Test, Gastric...
Enterin Meets Study Endpoints for the Phase 2b (KARMET) Study Involving Patients With Parkinson's Disease
January 27, 2022 09:00 ET
|
Enterin Inc.
PHILADELPHIA, Jan. 27, 2022 (GLOBE NEWSWIRE) -- Enterin Inc., a privately held, Philadelphia-based, clinical-stage biopharmaceutical company pioneering novel treatments for neurodegenerative and...
Global Constipation Treatment Market Trajectory & Analytics 2020-2027: U.S. Market is Estimated at $4.1 Billion, While China is Forecast to Grow at 9% CAGR
August 10, 2021 03:53 ET
|
Research and Markets
Dublin, Aug. 10, 2021 (GLOBE NEWSWIRE) -- The "Constipation Treatment - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.The global market for...
Life Extension Launches New Formula for Supporting Bowel Regularity
July 13, 2021 10:15 ET
|
Life Extension
Fort Lauderdale, July 13, 2021 (GLOBE NEWSWIRE) -- “Staying on schedule” goes hand in hand with digestive comfort. Life Extension’s new FLORASSIST® Daily Bowel Regularity contains clinically studied...
Global Irritable Bowel Syndrome (IBS) Diagnostics Market Forecast to 2028 - COVID-19 Impact and Analysis
June 09, 2021 06:28 ET
|
Research and Markets
Dublin, June 09, 2021 (GLOBE NEWSWIRE) -- The "Irritable Bowel Syndrome (IBS) Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Diagnosis (Laboratory Tests, Imaging...
BioDelivery Sciences to Report Second Quarter 2019 Financial Results and Host Conference Call on August 8, 2019
July 30, 2019 07:45 ET
|
BioDelivery Sciences International, Inc.
RALEIGH, N.C., July 30, 2019 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a specialty pharmaceutical company dedicated to patients living with chronic conditions,...
BioDelivery Sciences Expands Upon Report from Pain Management Task Force
June 24, 2019 08:00 ET
|
BioDelivery Sciences International, Inc.
Company’s Activities Support Buprenorphine Recommendations Including: Primary Use of Buprenorphine in Chronic Pain when Clinically IndicatedHaving Payers Provide Coverage and Reimbursement for...
FDA Advisory Committee Recommends Approval of Shire’s Prucalopride (SHP555) for Chronic Idiopathic Constipation
October 18, 2018 17:44 ET
|
Shire plc
Intended for U.S. Audience FDA Advisory Committee Recommends Approval of Shire’s Prucalopride (SHP555) for Chronic Idiopathic Constipation If FDA grants approval, prucalopride will be the only...
Sucampo Announces New Data on AMITIZA and Opioid-Induced Constipation Published Online in Pain Medicine Journal
May 06, 2014 06:45 ET
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., May 6, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, announced that its recent study, "A Randomized Study of...